4//SEC Filing
SHOVLIN ROBERT J. 4
Accession 0001077183-20-000116
CIK 0001077183other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:20 PM ET
Size
10.5 KB
Accession
0001077183-20-000116
Insider Transaction Report
Form 4
SHOVLIN ROBERT J.
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2020-05-25−5,405→ 146,235 total
Holdings
- 66,667
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (66,667 underlying) - 66,897
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (66,897 underlying) - 56,271
Stock Option (Right to Buy)
Exercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (56,271 underlying) - 96,167
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (96,167 underlying)
Footnotes (5)
- [F1]Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the May 25, 2020 vesting of restricted stock.
- [F2]On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001621453
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:20 PM ET
- Size
- 10.5 KB